Immediate effects of spinal manipulation, exercise therapy, and open-label placebo on lifting performance and pain in individuals with chronic non-specific back pain: a motion laboratory-based crossover randomized controlled trial.
6 affiliations
- 1Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Alfred Nobels Allé 23, Huddinge, Stockholm, 141 83, Sweden. [email protected].
- 2Scandinavian College of Chiropractic, Campus Solna, Fogdevreten 2A, 171 65 Solna, Stockholm, Sweden. [email protected].
- 3Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- 4Department of Neurobiology, Care Sciences and Society, Division of Physiotherapy, Karolinska Institutet, Alfred Nobels Allé 23, Huddinge, Stockholm, 141 83, Sweden.
- 5Medical Unit Allied Health Professionals, Karolinska University Hospital, Women's Health and Allied Health Professionals Theme, Stockholm, Sweden.
- 6School of Health and Welfare, Dalarna University, Falun, SE-791 88, Sweden.
Abstract
Background
Chronic non-specific back pain (CBP) is a leading cause of disability worldwide and is commonly associated with limitations in movements such as lifting. Although spinal manipulation (SMT) and exercise therapy (ET) are recommended treatments for CBP, their effects on objectively measured movement performance remain insufficiently explored. Open-label placebo (OLP) has gained attention for engaging placebo-related mechanisms ethically. This study aimed to investigate the immediate effects of SMT, ET, and OLP on lifting performance and pain in individuals with CBP, and to evaluate the add-on effects of OLP.Methods
A motion laboratory-based crossover randomized controlled trial included 50 individuals with CBP. Participants were recruited between April and July 2025 and attended a single laboratory session between September and October 2025. Participants performed lifting tasks using light and heavy loads before and after SMT, ET, and OLP interventions in randomized order. Three-dimensional motion capture was used to assess temporal, spatial, and spatiotemporal aspects of lifting performance. Subjective outcomes included pain intensity, perceived effectiveness, willingness to undergo each treatment, and treatment preference. Data were analyzed using linear mixed-effects models and functional data analysis.Results
Overall lifting performance changed to a small degree following the interventions. No significant between-group differences were observed at the primary endpoint. Significant within-group changes were observed following SMT, including altered intersegmental coordination during the light lift, characterized by a greater relative contribution of back movement early in the lifting phase, reduced thorax-pelvis tilt during the heavy lift, and reduced pain. OLP was associated with reduced thorax-pelvis tilt and increased hip and knee flexion during the light lift. Subjective evaluations did not consistently correspond to objective biomechanical changes.Conclusion
SMT, ET, and OLP demonstrated limited immediate effects on overall lifting performance in individuals with CBP. However, some within-group changes in thorax-pelvis movement and intersegmental coordination suggest that certain aspects of movement quality may respond to short-term interventions even when conventional biomechanical outcomes remain largely unchanged. The findings suggest the value of integrating subjective and objective outcomes, while advanced biomechanical analyses may provide insight into subtle movement changes in CBP.Trial registration
The trial is registered at ClinicalTrials.gov (ID NCT06891625).
Related
- Regarding "Stretching-Relaxation-Adjustment Manipulation versus Conventional Tuina for Non-Myelopathic Cervical Spondylosis: A Single-Blind Randomized Controlled Trial" [Response to Letter].
- Effects of grip strengthening combined with scapular stabilization exercise on shoulder muscle strength and functional outcomes in individuals with subacromial pain syndrome : A randomized controlled trial
- Effects of mindfulness-based yoga and physical exercise on psychological well-being in individuals with visual impairment: a three-armed randomized controlled trial
- Short-term subjective and EEG responses following cervical rotatory manipulation are not reproduced by simulated cracking sound: A randomized controlled study
- Closed reduction in distal radius fractures: manual manipulation vs. finger trap traction-a prospective randomized controlled clinical trial.
BibTeX
@article{borg2026immediate,
title = {{Immediate effects of spinal manipulation, exercise therapy, and open-label placebo on lifting performance and pain in individuals with chronic non-specific back pain: a motion laboratory-based crossover randomized controlled trial.}},
author = {Fredrik Borg and Filip Gedin and Erika Franzén and Wilhelmus Johannes Andreas Grooten},
journal = {Chiropractic \& manual therapies},
year = {2026},
month = oct,
doi = {10.1186/s12998-026-00680-w},
url = {https://europepmc.org/article/MED/42875790},
note = {CC BY},
}
RIS
TY - JOUR
TI - Immediate effects of spinal manipulation, exercise therapy, and open-label placebo on lifting performance and pain in individuals with chronic non-specific back pain: a motion laboratory-based crossover randomized controlled trial.
AU - Fredrik Borg
AU - Filip Gedin
AU - Erika Franzén
AU - Wilhelmus Johannes Andreas Grooten
PY - 2026
DA - 2026/10/14
JO - Chiropractic & manual therapies
DO - 10.1186/s12998-026-00680-w
UR - https://europepmc.org/article/MED/42875790
AB - Background Chronic non-specific back pain (CBP) is a leading cause of disability worldwide and is commonly associated with limitations in movements such as lifting. Although spinal manipulation (SMT) and exercise therapy (ET) are recommended treatments for CBP, their effects on objectively measured movement performance remain insufficiently explored. Open-label placebo (OLP) has gained attention for engaging placebo-related mechanisms ethically. This study aimed to investigate the immediate effects of SMT, ET, and OLP on lifting performance and pain in individuals with CBP, and to evaluate the add-on effects of OLP.Methods A motion laboratory-based crossover randomized controlled trial included 50 individuals with CBP. Participants were recruited between April and July 2025 and attended a single laboratory session between September and October 2025. Participants performed lifting tasks using light and heavy loads before and after SMT, ET, and OLP interventions in randomized order. Three-dimensional motion capture was used to assess temporal, spatial, and spatiotemporal aspects of lifting performance. Subjective outcomes included pain intensity, perceived effectiveness, willingness to undergo each treatment, and treatment preference. Data were analyzed using linear mixed-effects models and functional data analysis.Results Overall lifting performance changed to a small degree following the interventions. No significant between-group differences were observed at the primary endpoint. Significant within-group changes were observed following SMT, including altered intersegmental coordination during the light lift, characterized by a greater relative contribution of back movement early in the lifting phase, reduced thorax-pelvis tilt during the heavy lift, and reduced pain. OLP was associated with reduced thorax-pelvis tilt and increased hip and knee flexion during the light lift. Subjective evaluations did not consistently correspond to objective biomechanical changes.Conclusion SMT, ET, and OLP demonstrated limited immediate effects on overall lifting performance in individuals with CBP. However, some within-group changes in thorax-pelvis movement and intersegmental coordination suggest that certain aspects of movement quality may respond to short-term interventions even when conventional biomechanical outcomes remain largely unchanged. The findings suggest the value of integrating subjective and objective outcomes, while advanced biomechanical analyses may provide insight into subtle movement changes in CBP.Trial registration The trial is registered at ClinicalTrials.gov (ID NCT06891625).
SN - 2045-709X
ER -